Bespoke Extracts (BSPK) Cash from Financing Activities (2011 - 2025)

Bespoke Extracts (BSPK) reported Cash from Financing Activities of $35000.0 for Q3 2025, up 40.0% on a YoY basis from $25000.0 in Q3 2024, and up 1650.0% sequentially from $2000.0 in Q2 2025.

Bespoke Extracts (BSPK) Cash from Financing Activities (2011 - 2025) Analysis & Trends

Bespoke Extracts (BSPK) has 14 years of Cash from Financing Activities data on file, last reported at $35000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 40.0% year-over-year to $35000.0; the trailing twelve-month figure through Sep 2025 stood at $255000.0 (up 30.85% YoY), and the FY2024 full-year result was $343500.0, down 13.56% from the prior year.
  • Cash from Financing Activities climbed to $35000.0 in Q3 2025, from $2000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $600000.0 in Q1 2021 to a low of -$8957.0 in Q3 2023.
  • A 5-year average of $152286.1 and a median of $126099.5 in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities tumbled 105.6% in 2023 and soared 563.51% in 2024, its largest moves.
  • Tracing BSPK's Cash from Financing Activities over 5 years: stood at $25000.0 in 2021, then jumped by 922.01% to $255502.0 in 2022, then slumped by 89.68% to $26375.0 in 2023, then soared by 563.51% to $175000.0 in 2024, then plunged by 80.0% to $35000.0 in 2025.
  • Business Quant data shows BSPK's Cash from Financing Activities at $35000.0 in Q3 2025, $2000.0 in Q2 2025, and $43000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Bespoke Extracts 1.12 Mn 1.11 Mn 234,175.00 35,000.00

Historic Data

Download Data
DateValue
Sep 30, 2025 35,000.00
Sep 30, 2025 35,000.00
Jun 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 43,000.00
Mar 31, 2025 43,000.00
Dec 31, 2024 175,000.00
Dec 31, 2024 175,000.00
Sep 30, 2024 25,000.00
Sep 30, 2024 25,000.00
Jun 30, 2024 38,500.00
Jun 30, 2024 38,500.00
Mar 31, 2024 105,000.00
Mar 31, 2024 105,000.00
Dec 31, 2023 26,375.00
Dec 31, 2023 26,375.00
Sep 30, 2023 -8,957.00
Sep 30, 2023 -8,957.00
Jun 30, 2023 192,954.00
Jun 30, 2023 192,954.00